Further evidence supporting the global use of hydroxyurea
Blood Adv
.
2023 Oct 10;7(19):5968-5969.
doi: 10.1182/bloodadvances.2023010547.
Author
Natasha M Archer
1
2
Affiliations
1
Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.
2
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA.
PMID:
37815815
PMCID:
PMC10580264
DOI:
10.1182/bloodadvances.2023010547
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anemia, Sickle Cell*
Humans
Hydroxyurea / adverse effects
Malaria*
Substances
Hydroxyurea
Grants and funding
K08 DK123386/DK/NIDDK NIH HHS/United States